LENZ Therapeutics (LENZ) News Today $25.64 -0.89 (-3.35%) Closing price 04:00 PM EasternExtended Trading$25.66 +0.02 (+0.10%) As of 04:17 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period LENZ Therapeutics Stock Is Attractive Before PDUFAMarch 27 at 6:07 PM | seekingalpha.comEquities Analysts Offer Predictions for LENZ Q1 EarningsMarch 25 at 1:13 AM | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) vs. CARGO Therapeutics (NASDAQ:CRGX) Critical ReviewMarch 24, 2025 | americanbankingnews.comWhat is HC Wainwright's Forecast for LENZ Q2 Earnings?March 24, 2025 | americanbankingnews.comBrokers Issue Forecasts for LENZ Q2 EarningsLENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at HC Wainwright issued their Q2 2025 EPS estimates for LENZ Therapeutics in a research note issued to investors on Thursday, March 20th. HC Wainwright analyst M. Caufield anticipates that the company will earn ($0.60) perMarch 24, 2025 | marketbeat.comWhat is Leerink Partnrs' Forecast for LENZ Q1 Earnings?LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for LENZ Therapeutics in a research report issued to clients and investors on Wednesday, March 19th. Leerink Partnrs analyst M. Goodman anticipates thMarch 24, 2025 | marketbeat.comWilliam Blair Issues Negative Outlook for LENZ EarningsLENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Equities research analysts at William Blair reduced their Q1 2025 earnings estimates for shares of LENZ Therapeutics in a research note issued to investors on Thursday, March 20th. William Blair analyst L. Hanbury-Brown now forecasts that theMarch 24, 2025 | marketbeat.comWhat is William Blair's Estimate for LENZ FY2026 Earnings?March 23, 2025 | americanbankingnews.comWhat is HC Wainwright's Estimate for LENZ Q1 Earnings?March 23, 2025 | americanbankingnews.comFY2026 Earnings Forecast for LENZ Issued By William BlairLENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at William Blair issued their FY2026 earnings per share estimates for shares of LENZ Therapeutics in a research report issued to clients and investors on Thursday, March 20th. William Blair analyst L. Hanbury-Brown forecastMarch 22, 2025 | marketbeat.comQ1 Earnings Forecast for LENZ Issued By HC WainwrightLENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at HC Wainwright issued their Q1 2025 EPS estimates for shares of LENZ Therapeutics in a research note issued on Thursday, March 20th. HC Wainwright analyst M. Caufield expects that the company will post earnings of ($0.52)March 22, 2025 | marketbeat.comCitigroup Forecasts Strong Price Appreciation for LENZ Therapeutics (NASDAQ:LENZ) StockMarch 22, 2025 | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Expected to Rise, Citigroup Analyst SaysCitigroup lifted their target price on LENZ Therapeutics from $44.00 to $47.00 and gave the stock a "buy" rating in a research report on Thursday.March 21, 2025 | marketbeat.comEarnings call transcript: LENZ Therapeutics Q4 2024 shows innovation driveMarch 21, 2025 | uk.investing.comLENZ THERAPEUTICS Earnings Results: $LENZ Reports Quarterly EarningsMarch 21, 2025 | nasdaq.comLenz Therapeutics price target raised to $38 from $37 at BofAMarch 21, 2025 | markets.businessinsider.comLenz Therapeutics price target raised to $47 from $44 at CitiMarch 21, 2025 | markets.businessinsider.comAnalysts Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40March 21, 2025 | americanbankingnews.comLENZ Therapeutics (NASDAQ:LENZ) Posts Earnings Results, Misses Expectations By $0.05 EPSLENZ Therapeutics (NASDAQ:LENZ - Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.46) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.05).March 20, 2025 | marketbeat.comLENZ Therapeutics, Inc.: LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 20, 2025 | finanznachrichten.deLENZ Therapeutics (NASDAQ:LENZ) Coverage Initiated at TD CowenMarch 20, 2025 | americanbankingnews.comLENZ Therapeutics, Inc. (LENZ) Q4 2024 Earnings Call TranscriptMarch 19, 2025 | seekingalpha.comLenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progressMarch 19, 2025 | msn.comLENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate HighlightsMarch 19, 2025 | globenewswire.comLENZ Therapeutics (NASDAQ:LENZ) Shares Gap Up - Still a Buy?LENZ Therapeutics (NASDAQ:LENZ) Shares Gap Up - Should You Buy?March 19, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Buy" by AnalystsLENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has earned an average recommendation of "Buy" from the seven research firms that are covering the firm, MarketBeat Ratings reports. Six equities research analysts have rated the stock with a buy recommendation and one has issued a strong buyMarch 19, 2025 | marketbeat.comTD Cowen Begins Coverage on LENZ Therapeutics (NASDAQ:LENZ)TD Cowen initiated coverage on LENZ Therapeutics in a research report on Tuesday. They set a "buy" rating and a $60.00 price objective for the company.March 19, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6.1% - Here's What HappenedLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6.1% - Time to Sell?March 18, 2025 | marketbeat.comLenz Therapeutics initiated with a Buy at TD CowenMarch 18, 2025 | markets.businessinsider.comLENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume - What's Next?LENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume - Should You Buy?March 13, 2025 | marketbeat.comLENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025March 11, 2025 | globenewswire.comBML Capital Management LLC Has $268,000 Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ)BML Capital Management LLC lessened its holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 84.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,271 shares of the company's stock after selling 50,March 8, 2025 | marketbeat.comLENZ Therapeutics to Host Commercial Day on April 15, 2025March 3, 2025 | globenewswire.comLENZ Therapeutics to Participate in Upcoming Investor ConferencesFebruary 24, 2025 | globenewswire.comLENZ Therapeutics (LENZ) to Release Quarterly Earnings on WednesdayLENZ Therapeutics (NASDAQ:LENZ) will be releasing earnings before the market opens on Wednesday, February 26, Financial Modeling Prep reports.February 21, 2025 | marketbeat.comLENZ Therapeutics Insiders Placed Bullish Bets Worth US$551.1kFebruary 19, 2025 | finance.yahoo.comLENZ Stock Earnings: LENZ Therapeutics Misses EPS for Q1 2024February 14, 2025 | investorplace.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 4.7% - What's Next?LENZ Therapeutics (NASDAQ:LENZ) Trading Down 4.7% - Time to Sell?February 10, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Buy" by AnalystsShares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) have earned a consensus recommendation of "Buy" from the seven research firms that are currently covering the stock, Marketbeat.com reports. Six investment analysts have rated the stock with a buy recommendation and one has issuedFebruary 3, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Trading Up 8% - Here's WhyLENZ Therapeutics (NASDAQ:LENZ) Trading 8% Higher - What's Next?January 31, 2025 | marketbeat.comWhat is Leerink Partnrs' Estimate for LENZ FY2025 Earnings?LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) - Investment analysts at Leerink Partnrs cut their FY2025 earnings estimates for LENZ Therapeutics in a research report issued on Wednesday, January 29th. Leerink Partnrs analyst M. Goodman now expects that the company will post earnings per shaJanuary 31, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1% - What's Next?LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1% - Should You Sell?January 29, 2025 | marketbeat.comLENZ Therapeutics (LENZ) Expected to Announce Earnings on WednesdayLENZ Therapeutics (NASDAQ:LENZ) will be releasing earnings before the market opens on Wednesday, February 5, Financial Modeling Prep reports.January 29, 2025 | marketbeat.comLENZ Therapeutics, Inc. (LENZ)January 25, 2025 | ca.finance.yahoo.comBarclays PLC Has $391,000 Stake in LENZ Therapeutics, Inc. (NASDAQ:LENZ)Barclays PLC boosted its holdings in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) by 273.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 16,463 shares of the company's stoJanuary 19, 2025 | marketbeat.comShort Interest in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Expands By 11.9%LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 2,530,000 shares, an increase of 11.9% from the December 15th total of 2,260,000 shares. Based on an average trading volume of 154,500 shares, the days-to-cover ratio is currently 16.4 days. Currently, 11.3% of the company's shares are short sold.January 18, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Shares Down 5% - Time to Sell?LENZ Therapeutics (NASDAQ:LENZ) Shares Down 5% - What's Next?January 16, 2025 | marketbeat.comHarbor Capital Advisors Inc. Takes Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ)Harbor Capital Advisors Inc. bought a new position in shares of LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor bought 43,989 shares of theJanuary 13, 2025 | marketbeat.comLENZ Therapeutics (NASDAQ:LENZ) Shares Down 8.9% - Here's What HappenedLENZ Therapeutics (NASDAQ:LENZ) Trading Down 8.9% - Should You Sell?January 10, 2025 | marketbeat.comLENZ Therapeutics, Inc. (NASDAQ:LENZ) Receives Average Rating of "Buy" from BrokeragesLENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has received a consensus rating of "Buy" from the seven brokerages that are currently covering the firm, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has assigned a strong buyJanuary 9, 2025 | marketbeat.com Remove Ads Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address LENZ Media Mentions By Week LENZ Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LENZ News Sentiment▼0.700.78▲Average Medical News Sentiment LENZ News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LENZ Articles This Week▼263▲LENZ Articles Average Week Remove Ads Get LENZ Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LENZ and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACAD News Today MOR News Today XENE News Today AMRX News Today RXRX News Today TWST News Today BHC News Today NAMS News Today HCM News Today MLTX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LENZ) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredTrump’s Treasure Map [Pic inside]We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men...Paradigm Press | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LENZ Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LENZ Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy LENZ Stock Free LENZ Stock Alerts